Liquid biopsy in pancreatic ductal adenocarcinoma from diagnostic accuracy to clinical utility
Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed after the opportunity for curative treatment has passed. Blood-based biomarkers offer opportunities for earlier detection and serial molecular assessment, but their value depends on the intended clinical use. This nonsystematic narrative review critically exami...